BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7890601)

  • 1. Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect.
    Li CY; Suardet L; Little JB
    J Biol Chem; 1995 Mar; 270(10):4971-4. PubMed ID: 7890601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
    Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR
    Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.
    Datto MB; Li Y; Panus JF; Howe DJ; Xiong Y; Wang XF
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5545-9. PubMed ID: 7777546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta-induced cell-cycle arrest through the p21(WAF1/CIP1)-G1 cyclin/Cdks-p130 pathway in gastric-carcinoma cells.
    Yoo YD; Choi JY; Lee SJ; Kim JS; Min BR; Lee YI; Kang YK
    Int J Cancer; 1999 Nov; 83(4):512-7. PubMed ID: 10508488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B.
    Datto MB; Hu PP; Kowalik TF; Yingling J; Wang XF
    Mol Cell Biol; 1997 Apr; 17(4):2030-7. PubMed ID: 9121451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cell growth by transforming growth factor beta 1 is associated with p53-independent induction of p21 in gastric carcinoma cells.
    Akagi M; Yasui W; Akama Y; Yokozaki H; Tahara H; Haruma K; Kajiyama G; Tahara E
    Jpn J Cancer Res; 1996 Apr; 87(4):377-84. PubMed ID: 8641969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.
    Miyazaki M; Ohashi R; Tsuji T; Mihara K; Gohda E; Namba M
    Biochem Biophys Res Commun; 1998 May; 246(3):873-80. PubMed ID: 9618305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells.
    Weiss RH; Randour CJ
    Cell Signal; 2000 Jun; 12(6):413-8. PubMed ID: 10889470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-beta1-induced expression of p15/INK4B.
    Frost SJ; Simpson DJ; Farrell WE
    Mol Cell Endocrinol; 2001 May; 176(1-2):29-37. PubMed ID: 11369440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the glioblastoma cell cycle by type I IFNs occurs at both the G1 and S phases and correlates with the upregulation of p21(WAF1/CIP1).
    Tanabe T; Kominsky SL; Subramaniam PS; Johnson HM; Torres BA
    J Neurooncol; 2000 Jul; 48(3):225-32. PubMed ID: 11100820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells.
    Lee SJ; Ha MJ; Lee J; Nguyen P; Choi YH; Pirnia F; Kang WK; Wang XF; Kim SJ; Trepel JB
    J Biol Chem; 1998 Apr; 273(17):10618-23. PubMed ID: 9553123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
    Kim SG; Kim SN; Jong HS; Kim NK; Hong SH; Kim SJ; Bang YJ
    Oncogene; 2001 Mar; 20(10):1254-65. PubMed ID: 11313870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest.
    Patel V; Lahusen T; Sy T; Sausville EA; Gutkind JS; Senderowicz AM
    Cancer Res; 2002 Mar; 62(5):1401-9. PubMed ID: 11888912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1).
    Cheng T; Shen H; Rodrigues N; Stier S; Scadden DT
    Blood; 2001 Dec; 98(13):3643-9. PubMed ID: 11739168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
    Choi YH; Lee WH; Park KY; Zhang L
    Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells.
    Liu J; Estes ML; Drazba JA; Liu H; Prayson R; Kondo S; Jacobs BS; Barnett GH; Barna BP
    Oncogene; 2000 Feb; 19(5):661-9. PubMed ID: 10698511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
    Shi Y; Zou M; Farid NR; al-Sedairy ST
    Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.